Reuters logo
2 months ago
BRIEF-Quantum Genomics announces positive results of phase IIa study on QGC001
June 19, 2017 / 5:50 AM / 2 months ago

BRIEF-Quantum Genomics announces positive results of phase IIa study on QGC001

June 19 (Reuters) - QUANTUM GENOMICS SA:

* ANNOUNCES POSITIVE RESULTS OF ITS PHASE IIA STUDY ON QGC001 FOR TREATMENT OF HYPERTENSION

* LAUNCHES PHASE II CLINICAL STUDY‍​ IN THE US

* THESE DATA PAVE THE WAY FOR BRAIN AMINOPEPTIDASE A INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISEASES Source text: bit.ly/2sFWSiD Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below